Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook
Teladoc Health is rising Thursday after it reported better-than-expected Q3 results late Wednesday and raised its 2026 GAAP EPS guidance.
Share
Why It Matters
Teladoc did better than people expected in its latest quarter. They also said they will earn more money next year than they thought.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.